Sigma Foods (SIGMAF) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
29 Oct, 2026Executive summary
Record 3Q26 volume, revenue, and EBITDA; consolidated volume rose 2%, revenue 3%, and Comparable EBITDA 20% to $299M.
FY26 Comparable EBITDA guidance increased from $1.10B to $1.14B; EBITDA grew across all four regions, with Mexico delivering its strongest quarter.
Financial highlights
3Q revenue reached a record $2.493B, up 3% YoY; 9M revenue was $7.300B, up 7%.
3Q reported EBITDA was $303M, up 23%; Comparable EBITDA was $299M, up 20%, with a 12.0% margin versus 10.3% a year earlier.
9M reported EBITDA was $858M, up 5%; 9M Comparable EBITDA was $847M, up 18%, and volume reached a record 472k tons in 3Q.
3Q operating income rose 29% to $231M and net income rose 13% to $85M; 9M net income was $249M versus $284M.
3Q net financial cost was $90M, up 64% YoY, including $19M in FX losses versus a $13M FX gain in 3Q25; underlying expenses rose 3%.
Outlook and guidance
FY26 Comparable EBITDA guidance rose 4%, from $1.10B to $1.14B.
2027 planning anticipates supportive Americas raw-material trends, especially in H1, alongside U.S. volume-recovery initiatives and continued efficiency gains.
Valencia facility startup is expected in mid-2027; 2027 is expected to be the first full year after the majority-stake sale in Spain Fresh Meats.
Long-term ambition is to double the business over the next decade through protein-focused products, brands, and innovation.
Latest events from Sigma Foods
- Record food growth cushioned petrochemical weakness as impairments drove a $711M FY majority loss.SIGMAF
Q4 2023 - Global packaged food leader with robust growth, profitability, and strong sustainability focus.SIGMAF
Corporate presentation - Record 2Q revenue and EBITDA growth, with strong outlook and disciplined capital allocation.SIGMAF
Q2 2026 - Record revenue and EBITDA growth driven by brand strength, efficiency, and innovation.SIGMAF
Corporate presentation - Record Q1 volume, revenue, and EBITDA growth, with 2026 guidance reaffirmed.SIGMAF
Q1 2026 - Record revenues, margin expansion, Alpek spin-off, and strong 2026 outlook with increased dividends.SIGMAF
Q4 2025 - Sigma posts record EBITDA and sales as ALFA advances Alpek spin-off and reduces leverage.SIGMAF
Q3 2024 - 2Q24 EBITDA up 23% year-over-year; 2024 guidance raised on Sigma's strong results.SIGMAF
Q2 2024 - Transformation complete; Q1 2025 EBITDA $220M, on track for $1B annual target despite FX and cost pressures.SIGMAF
Q1 2025